Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.430
-0.010 (-0.69%)
At close: Dec 5, 2025, 4:00 PM EST
1.490
+0.060 (4.20%)
After-hours: Dec 5, 2025, 7:22 PM EST
Sunshine Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 7 | 6 | 7 | 14 | 30 | 5 | |
| Market Cap Growth | 53.87% | -13.95% | -51.77% | -52.26% | 480.17% | 1941.74% | |
| Enterprise Value | -1 | -6 | -11 | -26 | 32 | 6 | |
| Last Close Price | 1.43 | 3.00 | 543.00 | 1280.00 | 23380.00 | 6280.00 | |
| PS Ratio | 0.13 | 0.17 | 0.29 | 3.33 | 132.55 | 73.08 | |
| PB Ratio | 0.27 | 0.26 | 0.33 | 0.67 | 143.04 | -5.47 | |
| P/TBV Ratio | 0.32 | 0.29 | 0.35 | 0.69 | 271.15 | - | |
| EV/Sales Ratio | - | - | - | - | 137.98 | 81.76 | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.03 | 0.04 | 8.98 | -2.00 | |
| Asset Turnover | 1.21 | 1.20 | 0.85 | 0.28 | 0.14 | 0.13 | |
| Inventory Turnover | 2.09 | 2.85 | 3.49 | 1.56 | 1.82 | 1.30 | |
| Quick Ratio | 2.02 | 2.15 | 3.39 | 3.43 | 22.59 | 0.95 | |
| Current Ratio | 4.21 | 4.11 | 4.48 | 3.94 | 24.07 | 0.98 | |
| Return on Equity (ROE) | -24.34% | -22.97% | -21.04% | -244.92% | - | - | |
| Return on Assets (ROA) | -9.87% | -12.55% | -10.57% | -34.48% | -93.90% | -63.05% | |
| Return on Capital (ROIC) | -11.99% | -15.68% | -13.51% | -44.25% | -99.36% | -76.84% | |
| Return on Capital Employed (ROCE) | -19.60% | -24.00% | -22.00% | -38.90% | -115.60% | 9893.20% | |
| Earnings Yield | -85.42% | -85.58% | -64.63% | -185.03% | -41.08% | -53.35% | |
| FCF Yield | -105.55% | -236.51% | -127.05% | -37.65% | -6.04% | -12.62% | |
| Buyback Yield / Dilution | -1977.26% | -5371.73% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.